1. Home
  2. ONC vs DG Comparison

ONC vs DG Comparison

Compare ONC & DG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ONC
  • DG
  • Stock Information
  • Founded
  • ONC 2010
  • DG 1939
  • Country
  • ONC Switzerland
  • DG United States
  • Employees
  • ONC N/A
  • DG N/A
  • Industry
  • ONC Biotechnology: Pharmaceutical Preparations
  • DG Department/Specialty Retail Stores
  • Sector
  • ONC Health Care
  • DG Consumer Discretionary
  • Exchange
  • ONC Nasdaq
  • DG Nasdaq
  • Market Cap
  • ONC 31.5B
  • DG 25.3B
  • IPO Year
  • ONC N/A
  • DG N/A
  • Fundamental
  • Price
  • ONC $299.01
  • DG $108.53
  • Analyst Decision
  • ONC Strong Buy
  • DG Buy
  • Analyst Count
  • ONC 9
  • DG 23
  • Target Price
  • ONC $332.44
  • DG $110.29
  • AVG Volume (30 Days)
  • ONC 411.4K
  • DG 2.6M
  • Earning Date
  • ONC 08-06-2025
  • DG 08-28-2025
  • Dividend Yield
  • ONC N/A
  • DG 2.17%
  • EPS Growth
  • ONC N/A
  • DG N/A
  • EPS
  • ONC N/A
  • DG 5.24
  • Revenue
  • ONC $4,175,868,000.00
  • DG $41,134,266,000.00
  • Revenue This Year
  • ONC $865.19
  • DG $7.58
  • Revenue Next Year
  • ONC $21.12
  • DG $4.21
  • P/E Ratio
  • ONC N/A
  • DG $20.71
  • Revenue Growth
  • ONC 51.16
  • DG 4.77
  • 52 Week Low
  • ONC $155.75
  • DG $66.43
  • 52 Week High
  • ONC $308.87
  • DG $126.98
  • Technical
  • Relative Strength Index (RSI)
  • ONC N/A
  • DG 48.53
  • Support Level
  • ONC N/A
  • DG $104.50
  • Resistance Level
  • ONC N/A
  • DG $107.35
  • Average True Range (ATR)
  • ONC 0.00
  • DG 2.23
  • MACD
  • ONC 0.00
  • DG -0.62
  • Stochastic Oscillator
  • ONC 0.00
  • DG 41.63

About ONC BeiGene Ltd. American Depositary Shares

Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeiGene is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeiGene runs global clinical trials with its own team. As of 2024, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 60% of BeiGene's revenue.

About DG Dollar General Corporation

With more than 20,000 locations, Dollar General's banner is nearly ubiquitous across the rural United States. Dollar General serves as a convenient shopping destination for fill-in store trips, with its value proposition most relevant to consumers in small communities with a dearth of shopping options. The retailer operates a frugal store of about 7,500 square feet and primarily offers an assortment of branded and private-label consumable items (80% of net sales) such as paper and cleaning products, packaged food, and health and beauty items at low prices. Dollar General also offers a limited assortment of seasonal merchandise, home products, and apparel. The firm sells most items at a price point of $10 or less.

Share on Social Networks: